Foundry Partners’s Idexx Laboratories IDXX Stock Holding History

Foundry Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-810	Closed	-$437K	–	311
2024 Q1	$437K	Hold	810	–	–	0.02%	231
2023 Q4	$450K	Hold	810	–	–	0.03%	233
2023 Q3	$354K	Sell	810 -335	-29%	-$167K	0.02%	246
2023 Q2	$575K	Hold	1,145	–	–	0.04%	234
2023 Q1	$573K	Sell	1,145 -17	-1%	-$8.13K	0.04%	228
2022 Q4	$474K	Buy	1,162 +327	+39%	+$127K	0.03%	234
2022 Q3	$272K	Buy	835 +215	+35%	+$79K	0.02%	292
2022 Q2	$217K	Hold	620	–	–	0.01%	291
2022 Q1	$339K	Hold	620	–	–	0.02%	286
2021 Q4	$408K	Hold	620	–	–	0.01%	289
2021 Q3	$386K	Hold	620	–	–	0.01%	303
2021 Q2	$392K	Hold	620	–	–	0.01%	321
2021 Q1	$303K	Hold	620	–	–	0.01%	406
2020 Q4	$310K	Hold	620	–	–	0.01%	385
2020 Q3	$244K	Buy	+620	New	+$229K	0.01%	389

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Foundry Partners's IDXX Position: Q2 2024 in Review

Foundry Partners sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 810 shares — an estimated $437K sold.

Foundry Partners first reported a position in IDXX in Q3 2020 and held it in 15 quarters. The position peaked at $575K in Q2 2023. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Foundry Partners reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Foundry Partners sold 810 Idexx Laboratories shares in Q2 2024, an estimated $437K.
Foundry Partners first reported a position in Idexx Laboratories in Q3 2020 and held it in 15 quarters.
Foundry Partners's Idexx Laboratories position peaked at $575K in Q2 2023.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Foundry Partners's 13F filing for Q2 2024, filed 5 Aug 2024.